Reviewed by Peptide Treatments Medical Advisory Board
Efinopegdutide: Side Effects & Safety
Known side effects, safety considerations, and adverse reaction data for Efinopegdutide.
Back to Efinopegdutide overviewData source: Side effect data comes from clinical trials, preclinical research, and anecdotal reports. No FDA-approved labeling exists for this compound.
Reported Side Effects (7 items)
| # | Side Effect |
|---|---|
| 1 | Nausea |
| 2 | Diarrhea |
| 3 | Vomiting |
| 4 | GI adverse events (slightly higher than semaglutide in Phase 2a) |
| 5 | Theoretical risk of hyperglucagonemia from glucagon receptor activation |
| 6 | Theoretical risk of gastroparesis (GLP-1 class effect) |
| 7 | Theoretical risk of pancreatitis (GLP-1 class effect) |